MD Anderson supports FDA proposal to prohibit menthol cigarettes
The University of Texas MD Anderson Cancer Center strongly encourages endorsement of the Food and Drug Administration (FDA) proposed rules to prohibit menthol cigarettes and flavored cigars.
The FDA banned the use of flavors in cigarettes in 2009, except for menthol. Today’s announcement represents a historic step closer to removing menthol cigarettes from the market. Once finalized, the product standards are...
Antiviral T cells safe and effective for treating debilitating complication common after stem cell transplants
A Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center found that BK virus (BKV)-specific T cells from healthy...
MD Anderson advances data collaboration through technology agreement with Syntropy
The University of Texas MD Anderson Cancer Center today announced efforts to advance its capabilities to seamlessly connect basic science,...
ASCO recognizes three MD Anderson faculty with highest honors
The American Society of Clinical Oncology (ASCO) today announced it will present three of its highest honors to faculty members from The University of Texas MD Anderson Cancer Center during its virtual annual meeting in June. The three faculty members to be honored for their significant contributions to oncology are:
Maura Gillison, M.D., Ph.D., professor of Thoracic/Head and Neck Medical Oncology, will receive the David A. Karnofsky...MD Anderson researcher Sharon Dent elected to American Academy of Arts and Sciences
Sharon Dent, Ph.D., professor of Epigenetics and Molecular Carcinogenesis, and director of the Virginia Harris Cockrell Cancer Research Center...
MD Anderson and Boehringer Ingelheim expand collaboration to advance lung cancer therapies
The University of Texas MD Anderson Cancer Center and Boehringer Ingelheim today announced the extension and expansion of their joint Virtual...
Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug conjugates
Abstract #LB008
A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug...
MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021
Early phase clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients...
Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
ABSTRACT #2417
Researchers at The University of Texas MD Anderson Cancer Center have discovered that mutant KRAS and p53, the most...
MD Anderson researchers recognized by AACR
Three researchers from The University of Texas MD Anderson Cancer Center have been honored by the American Association for Cancer Research...
MD Anderson and TriSalus Life Sciences announce strategic research collaboration to evaluate treatment of solid tumors
The University of Texas MD Anderson Cancer Center and TriSalus Life Sciences today announced a strategic research collaboration to evaluate...
Genetic diversity within tumors suggests continuous evolution
By analyzing tumors from more than 2,600 patients and from 38 cancer types, researchers from The University of Texas MD Anderson Cancer Center...